AAAAAA
Results:
1-13
|
Results: 13
Authors:
HAGEBOUTROS A
HUDES GR
GREENE F
LACRETA FP
BRENNAN J
ODWYER PJ
Citation: A. Hageboutros et al., PHASE-I TRIAL OF FLUOROURACIL MODULATION BY N-PHOSPHONACETYL-L-ASPARTATE AND 6-METHYLMERCAPTOPURINE RIBONUCLEOSIDE (MMPR), AND LEUCOVORIN IN PATIENTS WITH ADVANCED CANCER, Investigational new drugs, 15(2), 1997, pp. 139-145
Authors:
ODWYER PJ
HAMILTON TC
LACRETA FP
GALLO JM
KILPATRICK D
HALBHERR T
BRENNAN J
BOOKMAN MA
HOFFMAN J
YOUNG RC
COMIS RL
OZOLS RF
Citation: Pj. Odwyer et al., PHASE-I TRIAL OF BUTHIONINE SULFOXIMINE IN COMBINATION WITH MELPHALANIN PATIENTS WITH CANCER, Journal of clinical oncology, 14(1), 1996, pp. 249-256
Authors:
HAGEBOUTROS A
HUDES GR
BRENNAN J
GREEN F
HOFFMAN J
LACRETA FP
COLOFIORE J
MARTIN DS
OZOLS RF
ODWYER PJ
Citation: A. Hageboutros et al., PHASE-I TRIAL OF FLUOROURACIL MODULATION BY N-PHOSPHONACETYL-L-ASPARTATE AND 6-METHYLMERCAPTOPURINE RIBONUCLEOSIDE, Cancer chemotherapy and pharmacology, 37(3), 1996, pp. 229-234
Authors:
HAGEBOUTROS A
ROGATKO A
NEWMAN EM
MCALEER C
BRENNAN J
LACRETA FP
HUDES GR
OZOLS RF
ODWYER PJ
Citation: A. Hageboutros et al., PHASE-I STUDY OF PHOSPHONACETYL-L-ASPARTATE, 5-FLUOROURACIL, AND LEUCOVORIN IN PATIENTS WITH ADVANCED CANCER, Cancer chemotherapy and pharmacology, 35(3), 1995, pp. 205-212
Authors:
ODWYER PJ
LACRETA FP
HAAS NB
HALBHERR T
FRUCHT H
GOOSENBERG E
YAO KS
Citation: Pj. Odwyer et al., CLINICAL, PHARMACOKINETIC AND BIOLOGICAL STUDIES OF TOPOTECAN, Cancer chemotherapy and pharmacology, 34, 1994, pp. 190000046-190000052
Authors:
LACRETA FP
BRENNAN JM
HAMILTON TC
OZOLS RF
ODWYER PJ
Citation: Fp. Lacreta et al., STEREOSELECTIVE PHARMACOKINETICS OF L-BUTHIONINE SR-SULFOXIMINE IN PATIENTS WITH CANCER, Drug metabolism and disposition, 22(6), 1994, pp. 835-842
Authors:
LACRETA FP
BRENNAN JM
NASH SL
COMIS RL
TEW KD
ODWYER PJ
Citation: Fp. Lacreta et al., PHARMACOKINETICS AND BIOAVAILABILITY STUDY OF ETHACRYNIC-ACID AS A MODULATOR OF DRUG-RESISTANCE IN PATIENTS WITH CANCER, The Journal of pharmacology and experimental therapeutics, 270(3), 1994, pp. 1186-1191
Authors:
HAAS NB
LACRETA FP
WALCZAK J
HUDES GR
BRENNAN JM
OZOLS RF
ODWYER PJ
Citation: Nb. Haas et al., PHASE-I PHARMACOKINETIC STUDY OF TOPOTECAN BY 24-HOUR CONTINUOUS-INFUSION WEEKLY, Cancer research, 54(5), 1994, pp. 1220-1226
Authors:
SCHILDER RJ
LACRETA FP
PEREZ RP
JOHNSON SW
BRENNAN JM
ROGATKO A
NASH S
MCALEER C
HAMILTON TC
ROBY D
YOUNG RC
OZOLS RF
ODWYER PJ
Citation: Rj. Schilder et al., PHASE-I AND PHARMACOKINETIC STUDY OF ORMAPLATIN (TETRAPLATIN, NSC-363812) ADMINISTERED ON A DAY-1 AND DAY-8 SCHEDULE, Cancer research, 54(3), 1994, pp. 709-717
Authors:
BRENNAN JM
ODWYER PJ
OZOLS RF
LACRETA FP
Citation: Jm. Brennan et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF THE S-DIASTEREOISOMERS AND R-DIASTEREOISOMERS OF L-BUTHIONINE (SR)-SULFOXIMINE IN HUMAN PLASMA AND URINE, Journal of chromatography. Biomedical applications, 620(1), 1993, pp. 121-128
Authors:
LANGER CJ
ROSENBLUM N
HOGAN M
NASH S
BAGCHI P
LACRETA FP
CATALANO R
COMIS RL
ODWYER PJ
Citation: Cj. Langer et al., INTRAPERITONEAL CISPLATIN AND ETOPOSIDE IN PERITONEAL MESOTHELIOMA - FAVORABLE OUTCOME WITH A MULTIMODALITY APPROACH, Cancer chemotherapy and pharmacology, 32(3), 1993, pp. 204-208
Authors:
ODWYER PJ
LACRETA FP
WALCZAK J
COX T
LITWIN S
HOFFMAN JP
ZIMNY M
COMIS RL
Citation: Pj. Odwyer et al., PHASE-I PHARMACOKINETIC BIOCHEMICAL-STUDY OF THE NITROIMADAZOLE HYPOXIC CELL SENSITIZER SR2508 (ETANIDAZOLE) IN COMBINATION WITH CYCLOPHOSPHAMIDE, British Journal of Cancer, 68(4), 1993, pp. 756-766
Authors:
ODWYER PJ
PANTING L
LACRETA FP
CLAPPER ML
Citation: Pj. Odwyer et al., SR2508 (ETANIDAZOLE) PHARMACOKINETICS AND BIOCHEMICAL EFFECTS IN TUMOR AND NORMAL-TISSUES OF SCID MICE BEARING HT-29 HUMAN COLON ADENOCARCINOMA, Biochemical pharmacology, 46(7), 1993, pp. 1251-1256
Risultati:
1-13
|